1. Horoszewicz JS, Leong SS, Kawinski E et al (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43:1809–1818
2. Horoszewicz JS, Kawinski E, Murphy GP (1987) Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 7:927–935
3. Su SL, Huang IP, Fair WR et al (1995) Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res 55:1441–1443
4. Davis MI, Bennett MJ, Thomas LM et al (2005) Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci U S A 102:5981–5986
5. Mease RC, Foss CA, Pomper MG (2013) PET imaging in prostate cancer: focus on prostate-specific membrane antigen. Curr Top Med Chem 13:951–962